nodes	percent_of_prediction	percent_of_DWPC	metapath
Canagliflozin—ALB—Liothyronine—hypothyroidism	0.164	0.206	CbGbCtD
Canagliflozin—ALB—Levothyroxine—hypothyroidism	0.164	0.206	CbGbCtD
Canagliflozin—ALB—Liotrix—hypothyroidism	0.16	0.201	CbGbCtD
Canagliflozin—ABCB1—Liothyronine—hypothyroidism	0.0858	0.108	CbGbCtD
Canagliflozin—ABCB1—Levothyroxine—hypothyroidism	0.0858	0.108	CbGbCtD
Canagliflozin—ABCB1—Liotrix—hypothyroidism	0.0838	0.105	CbGbCtD
Canagliflozin—CYP3A4—Levothyroxine—hypothyroidism	0.0514	0.0647	CbGbCtD
Canagliflozin—SLC5A2—urine—hypothyroidism	0.0346	0.308	CbGeAlD
Canagliflozin—SLC5A1—heart—hypothyroidism	0.00671	0.0598	CbGeAlD
Canagliflozin—SLC5A2—blood—hypothyroidism	0.00661	0.0589	CbGeAlD
Canagliflozin—SLC5A1—cardiovascular system—hypothyroidism	0.00633	0.0565	CbGeAlD
Canagliflozin—UGT2B4—heart—hypothyroidism	0.00618	0.0551	CbGeAlD
Canagliflozin—UGT2B4—cardiovascular system—hypothyroidism	0.00583	0.052	CbGeAlD
Canagliflozin—SLC5A1—pituitary gland—hypothyroidism	0.00561	0.05	CbGeAlD
Canagliflozin—SLC5A2—testis—hypothyroidism	0.00546	0.0487	CbGeAlD
Canagliflozin—SLC5A1—testis—hypothyroidism	0.00414	0.0369	CbGeAlD
Canagliflozin—CYP3A4—urine—hypothyroidism	0.00362	0.0323	CbGeAlD
Canagliflozin—UGT2B4—liver—hypothyroidism	0.00361	0.0322	CbGeAlD
Canagliflozin—SLC5A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00266	0.0854	CbGpPWpGaD
Canagliflozin—SLC5A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00266	0.0854	CbGpPWpGaD
Canagliflozin—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00263	0.0426	CcSEcCtD
Canagliflozin—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00263	0.0426	CcSEcCtD
Canagliflozin—UGT1A9—liver—hypothyroidism	0.00246	0.022	CbGeAlD
Canagliflozin—Blood urea increased—Liotrix—hypothyroidism	0.00245	0.0397	CcSEcCtD
Canagliflozin—Hypotension—Liothyronine—hypothyroidism	0.0024	0.0388	CcSEcCtD
Canagliflozin—Dehydration—Dextrothyroxine—hypothyroidism	0.00238	0.0386	CcSEcCtD
Canagliflozin—Dehydration—Levothyroxine—hypothyroidism	0.00238	0.0386	CcSEcCtD
Canagliflozin—Renal failure acute—Liotrix—hypothyroidism	0.00204	0.0331	CcSEcCtD
Canagliflozin—ALB—heart—hypothyroidism	0.00195	0.0174	CbGeAlD
Canagliflozin—Hypoglycaemia—Liotrix—hypothyroidism	0.00193	0.0313	CcSEcCtD
Canagliflozin—SLC5A2—NRF2 pathway—SLC5A7—hypothyroidism	0.00192	0.0615	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—SLC5A7—hypothyroidism	0.00192	0.0615	CbGpPWpGaD
Canagliflozin—Blood creatinine increased—Liotrix—hypothyroidism	0.00177	0.0286	CcSEcCtD
Canagliflozin—Dehydration—Liotrix—hypothyroidism	0.00175	0.0284	CcSEcCtD
Canagliflozin—ORM1—blood—hypothyroidism	0.00166	0.0148	CbGeAlD
Canagliflozin—ALB—adrenal gland—hypothyroidism	0.00145	0.013	CbGeAlD
Canagliflozin—Angioedema—Dextrothyroxine—hypothyroidism	0.00141	0.0229	CcSEcCtD
Canagliflozin—Angioedema—Levothyroxine—hypothyroidism	0.00141	0.0229	CcSEcCtD
Canagliflozin—ABCC2—adrenal gland—hypothyroidism	0.00136	0.0122	CbGeAlD
Canagliflozin—ABCC2—blood—hypothyroidism	0.00136	0.0122	CbGeAlD
Canagliflozin—Convulsion—Levothyroxine—hypothyroidism	0.00134	0.0217	CcSEcCtD
Canagliflozin—Convulsion—Dextrothyroxine—hypothyroidism	0.00134	0.0217	CcSEcCtD
Canagliflozin—ORM1—liver—hypothyroidism	0.0013	0.0116	CbGeAlD
Canagliflozin—Shock—Levothyroxine—hypothyroidism	0.00124	0.0201	CcSEcCtD
Canagliflozin—Shock—Dextrothyroxine—hypothyroidism	0.00124	0.0201	CcSEcCtD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00121	0.0388	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00121	0.0388	CbGpPWpGaD
Canagliflozin—ALB—testis—hypothyroidism	0.0012	0.0107	CbGeAlD
Canagliflozin—ALB—liver—hypothyroidism	0.00114	0.0101	CbGeAlD
Canagliflozin—ABCC2—testis—hypothyroidism	0.00113	0.0101	CbGeAlD
Canagliflozin—Fatigue—Dextrothyroxine—hypothyroidism	0.00109	0.0176	CcSEcCtD
Canagliflozin—Fatigue—Levothyroxine—hypothyroidism	0.00109	0.0176	CcSEcCtD
Canagliflozin—ABCC2—liver—hypothyroidism	0.00107	0.0095	CbGeAlD
Canagliflozin—Angioedema—Liotrix—hypothyroidism	0.00104	0.0168	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00103	0.0167	CcSEcCtD
Canagliflozin—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00103	0.0167	CcSEcCtD
Canagliflozin—Syncope—Liotrix—hypothyroidism	0.00102	0.0165	CcSEcCtD
Canagliflozin—Urticaria—Levothyroxine—hypothyroidism	0.001	0.0162	CcSEcCtD
Canagliflozin—Urticaria—Dextrothyroxine—hypothyroidism	0.001	0.0162	CcSEcCtD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.001	0.0321	CbGpPWpGaD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.001	0.0321	CbGpPWpGaD
Canagliflozin—Loss of consciousness—Liotrix—hypothyroidism	0.000998	0.0162	CcSEcCtD
Canagliflozin—Abdominal pain—Levothyroxine—hypothyroidism	0.000996	0.0161	CcSEcCtD
Canagliflozin—Abdominal pain—Dextrothyroxine—hypothyroidism	0.000996	0.0161	CcSEcCtD
Canagliflozin—Convulsion—Liotrix—hypothyroidism	0.000984	0.0159	CcSEcCtD
Canagliflozin—Infection—Liotrix—hypothyroidism	0.000921	0.0149	CcSEcCtD
Canagliflozin—Shock—Liotrix—hypothyroidism	0.000912	0.0148	CcSEcCtD
Canagliflozin—Asthenia—Levothyroxine—hypothyroidism	0.000904	0.0146	CcSEcCtD
Canagliflozin—Asthenia—Dextrothyroxine—hypothyroidism	0.000904	0.0146	CcSEcCtD
Canagliflozin—Pruritus—Dextrothyroxine—hypothyroidism	0.000891	0.0144	CcSEcCtD
Canagliflozin—Pruritus—Levothyroxine—hypothyroidism	0.000891	0.0144	CcSEcCtD
Canagliflozin—Hypotension—Liotrix—hypothyroidism	0.000866	0.014	CcSEcCtD
Canagliflozin—Fatigue—Liotrix—hypothyroidism	0.000799	0.0129	CcSEcCtD
Canagliflozin—Rash—Levothyroxine—hypothyroidism	0.000794	0.0129	CcSEcCtD
Canagliflozin—Rash—Dextrothyroxine—hypothyroidism	0.000794	0.0129	CcSEcCtD
Canagliflozin—Dermatitis—Levothyroxine—hypothyroidism	0.000794	0.0129	CcSEcCtD
Canagliflozin—Dermatitis—Dextrothyroxine—hypothyroidism	0.000794	0.0129	CcSEcCtD
Canagliflozin—Constipation—Liotrix—hypothyroidism	0.000792	0.0128	CcSEcCtD
Canagliflozin—SLC5A2—NRF2 pathway—SLC5A5—hypothyroidism	0.000765	0.0246	CbGpPWpGaD
Canagliflozin—SLC5A1—NRF2 pathway—SLC5A5—hypothyroidism	0.000765	0.0246	CbGpPWpGaD
Canagliflozin—Gastrointestinal pain—Liotrix—hypothyroidism	0.000758	0.0123	CcSEcCtD
Canagliflozin—Nausea—Levothyroxine—hypothyroidism	0.000748	0.0121	CcSEcCtD
Canagliflozin—Nausea—Dextrothyroxine—hypothyroidism	0.000748	0.0121	CcSEcCtD
Canagliflozin—Urticaria—Liotrix—hypothyroidism	0.000736	0.0119	CcSEcCtD
Canagliflozin—Abdominal pain—Liotrix—hypothyroidism	0.000733	0.0119	CcSEcCtD
Canagliflozin—ALB—Transport of organic anions—AVP—hypothyroidism	0.000714	0.0229	CbGpPWpGaD
Canagliflozin—CYP3A4—blood—hypothyroidism	0.000692	0.00617	CbGeAlD
Canagliflozin—Hypersensitivity—Liotrix—hypothyroidism	0.000683	0.0111	CcSEcCtD
Canagliflozin—ABCB1—adrenal cortex—hypothyroidism	0.000679	0.00606	CbGeAlD
Canagliflozin—Asthenia—Liotrix—hypothyroidism	0.000665	0.0108	CcSEcCtD
Canagliflozin—ABCB1—heart—hypothyroidism	0.000657	0.00586	CbGeAlD
Canagliflozin—Pruritus—Liotrix—hypothyroidism	0.000656	0.0106	CcSEcCtD
Canagliflozin—ALB—FOXA2 and FOXA3 transcription factor networks—NKX2-1—hypothyroidism	0.00062	0.0199	CbGpPWpGaD
Canagliflozin—ABCB1—cardiovascular system—hypothyroidism	0.00062	0.00553	CbGeAlD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000613	0.0197	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000613	0.0197	CbGpPWpGaD
Canagliflozin—Dizziness—Liotrix—hypothyroidism	0.000613	0.00993	CcSEcCtD
Canagliflozin—Rash—Liotrix—hypothyroidism	0.000584	0.00947	CcSEcCtD
Canagliflozin—Dermatitis—Liotrix—hypothyroidism	0.000584	0.00946	CcSEcCtD
Canagliflozin—ABCB1—gonad—hypothyroidism	0.000562	0.00502	CbGeAlD
Canagliflozin—Nausea—Liotrix—hypothyroidism	0.00055	0.00892	CcSEcCtD
Canagliflozin—ABCB1—pituitary gland—hypothyroidism	0.000549	0.00489	CbGeAlD
Canagliflozin—UGT1A9—NRF2 pathway—SLC5A7—hypothyroidism	0.000547	0.0176	CbGpPWpGaD
Canagliflozin—CYP3A4—liver—hypothyroidism	0.000541	0.00483	CbGeAlD
Canagliflozin—ABCC2—NRF2 pathway—SLC5A7—hypothyroidism	0.000534	0.0172	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000508	0.0163	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000508	0.0163	CbGpPWpGaD
Canagliflozin—ABCB1—adrenal gland—hypothyroidism	0.00049	0.00437	CbGeAlD
Canagliflozin—ABCB1—blood—hypothyroidism	0.00049	0.00437	CbGeAlD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000482	0.0155	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000482	0.0155	CbGpPWpGaD
Canagliflozin—ABCB1—thyroid gland—hypothyroidism	0.000473	0.00422	CbGeAlD
Canagliflozin—ABCB1—female gonad—hypothyroidism	0.000457	0.00408	CbGeAlD
Canagliflozin—SLC5A1—Metabolism—IYD—hypothyroidism	0.000414	0.0133	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—IYD—hypothyroidism	0.000414	0.0133	CbGpPWpGaD
Canagliflozin—ABCB1—testis—hypothyroidism	0.000405	0.00361	CbGeAlD
Canagliflozin—ABCB1—liver—hypothyroidism	0.000383	0.00342	CbGeAlD
Canagliflozin—SLC5A1—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.00038	0.0122	CbGpPWpGaD
Canagliflozin—SLC5A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.00038	0.0122	CbGpPWpGaD
Canagliflozin—ABCB1—cerebellum—hypothyroidism	0.000374	0.00334	CbGeAlD
Canagliflozin—SLC5A2—Metabolism—ATP5O—hypothyroidism	0.000352	0.0113	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—ATP5O—hypothyroidism	0.000352	0.0113	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—TPO—hypothyroidism	0.000331	0.0106	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—TPO—hypothyroidism	0.000331	0.0106	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—IYD—hypothyroidism	0.00032	0.0103	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—ATP5O—hypothyroidism	0.000272	0.00874	CbGpPWpGaD
Canagliflozin—UGT2B4—Biological oxidations—POMC—hypothyroidism	0.000271	0.00872	CbGpPWpGaD
Canagliflozin—ALB—Transport of vitamins, nucleosides, and related molecules—AVP—hypothyroidism	0.000265	0.00851	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—TPO—hypothyroidism	0.000256	0.00822	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000245	0.00788	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000245	0.00788	CbGpPWpGaD
Canagliflozin—UGT1A9—NRF2 pathway—SLC5A5—hypothyroidism	0.000219	0.00703	CbGpPWpGaD
Canagliflozin—ABCC2—NRF2 pathway—SLC5A5—hypothyroidism	0.000213	0.00686	CbGpPWpGaD
Canagliflozin—SLC5A1—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000193	0.0062	CbGpPWpGaD
Canagliflozin—SLC5A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000193	0.0062	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.000181	0.0058	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000171	0.0055	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—TSHB—hypothyroidism	0.000153	0.00493	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—TSHB—hypothyroidism	0.000153	0.00493	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00015	0.00481	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000142	0.00455	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—PIK3C2A—hypothyroidism	0.000137	0.00439	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—PIK3C2A—hypothyroidism	0.000137	0.00439	CbGpPWpGaD
Canagliflozin—SLC5A2—Disease—PRL—hypothyroidism	0.000121	0.00389	CbGpPWpGaD
Canagliflozin—SLC5A1—Disease—PRL—hypothyroidism	0.000121	0.00389	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—IYD—hypothyroidism	0.000118	0.00381	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—TSHB—hypothyroidism	0.000118	0.00381	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—SLC5A5—hypothyroidism	0.000115	0.00369	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—SLC5A5—hypothyroidism	0.000115	0.00369	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—PIK3C2A—hypothyroidism	0.000106	0.00339	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—ATP5O—hypothyroidism	0.000101	0.00324	CbGpPWpGaD
Canagliflozin—UGT1A9—Biological oxidations—POMC—hypothyroidism	0.0001	0.00323	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—TPO—hypothyroidism	9.47e-05	0.00304	CbGpPWpGaD
Canagliflozin—ALB—Platelet degranulation—IGF1—hypothyroidism	9.33e-05	0.003	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	9.18e-05	0.00295	CbGpPWpGaD
Canagliflozin—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—hypothyroidism	8.88e-05	0.00286	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—SLC5A5—hypothyroidism	8.87e-05	0.00285	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	8.77e-05	0.00282	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	8.04e-05	0.00258	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	7.6e-05	0.00244	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	7.22e-05	0.00232	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	6.84e-05	0.0022	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	6.72e-05	0.00216	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	6.66e-05	0.00214	CbGpPWpGaD
Canagliflozin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	6.59e-05	0.00212	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—IYD—hypothyroidism	6.2e-05	0.00199	CbGpPWpGaD
Canagliflozin—SLC5A2—Metabolism—POMC—hypothyroidism	6.01e-05	0.00193	CbGpPWpGaD
Canagliflozin—SLC5A1—Metabolism—POMC—hypothyroidism	6.01e-05	0.00193	CbGpPWpGaD
Canagliflozin—ALB—SLC-mediated transmembrane transport—AVP—hypothyroidism	5.68e-05	0.00183	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—IYD—hypothyroidism	5.43e-05	0.00175	CbGpPWpGaD
Canagliflozin—ABCC2—Transmembrane transport of small molecules—AVP—hypothyroidism	5.38e-05	0.00173	CbGpPWpGaD
Canagliflozin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	5.34e-05	0.00172	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—ATP5O—hypothyroidism	5.27e-05	0.00169	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—SH2B3—hypothyroidism	5.04e-05	0.00162	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—TPO—hypothyroidism	4.96e-05	0.00159	CbGpPWpGaD
Canagliflozin—UGT2B4—Metabolism—POMC—hypothyroidism	4.64e-05	0.00149	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—ATP5O—hypothyroidism	4.62e-05	0.00148	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	4.59e-05	0.00148	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—TSHB—hypothyroidism	4.38e-05	0.00141	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—TPO—hypothyroidism	4.34e-05	0.0014	CbGpPWpGaD
Canagliflozin—ALB—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	4.14e-05	0.00133	CbGpPWpGaD
Canagliflozin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—hypothyroidism	4.07e-05	0.00131	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—PIK3C2A—hypothyroidism	3.91e-05	0.00126	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	3.85e-05	0.00124	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.67e-05	0.00118	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—VAV3—hypothyroidism	3.46e-05	0.00111	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—IYD—hypothyroidism	3.35e-05	0.00108	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—SLC5A5—hypothyroidism	3.28e-05	0.00105	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	3.21e-05	0.00103	CbGpPWpGaD
Canagliflozin—ALB—Transmembrane transport of small molecules—AVP—hypothyroidism	2.89e-05	0.000928	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—ATP5O—hypothyroidism	2.85e-05	0.000915	CbGpPWpGaD
Canagliflozin—CYP3A4—Biological oxidations—POMC—hypothyroidism	2.84e-05	0.000912	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—TPO—hypothyroidism	2.68e-05	0.00086	CbGpPWpGaD
Canagliflozin—ABCB1—Transmembrane transport of small molecules—AVP—hypothyroidism	2.53e-05	0.000813	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—TSHB—hypothyroidism	2.29e-05	0.000738	CbGpPWpGaD
Canagliflozin—ALB—Hemostasis—IGF1—hypothyroidism	2.13e-05	0.000685	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—PIK3C2A—hypothyroidism	2.05e-05	0.000657	CbGpPWpGaD
Canagliflozin—ALB—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	2.02e-05	0.000649	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—TSHB—hypothyroidism	2.01e-05	0.000646	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—PIK3C2A—hypothyroidism	1.79e-05	0.000576	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—SLC5A5—hypothyroidism	1.72e-05	0.000552	CbGpPWpGaD
Canagliflozin—UGT1A9—Metabolism—POMC—hypothyroidism	1.72e-05	0.000552	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—SLC5A5—hypothyroidism	1.51e-05	0.000484	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—TSHB—hypothyroidism	1.24e-05	0.000398	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	1.1e-05	0.000355	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—SLC5A5—hypothyroidism	9.27e-06	0.000298	CbGpPWpGaD
Canagliflozin—ALB—Metabolism—POMC—hypothyroidism	8.99e-06	0.000289	CbGpPWpGaD
Canagliflozin—ABCB1—Metabolism—POMC—hypothyroidism	7.88e-06	0.000253	CbGpPWpGaD
Canagliflozin—CYP3A4—Metabolism—POMC—hypothyroidism	4.85e-06	0.000156	CbGpPWpGaD
